Semaglutide Improves Clinical and Metabolic Outcomes in Hidradenitis Suppurativa with Obesity: Study Medha Baranwal18 March 2026 10:00 AM ISTSpain: A new study has found that treatment with Semaglutide in patients with Hidradenitis Suppurativa and obesity led to improvements in weight, body...
Semaglutide may Improve Insulin Sensitivity in Schizophrenia Patients with Prediabetes: Study suggests Medha Baranwal14 March 2026 10:00 AM ISTDenmark: A study published in Diabetes Care has revealed that semaglutide improves insulin sensitivity in patients with schizophrenia who have...
GLP-1 medications get at the heart of addiction: study Dr. Kamal Kant Kohli10 March 2026 9:00 PM ISTResearchers at Washington University School of Medicine in St. Louis show in a new study that GLP-1 medications may be effective at treating and...
MASLD in T2D: Why Weight Loss Is More Than Cosmetic? Dr. Kamal Kant Kohli10 March 2026 10:26 AM ISTIndia's diabetes burden is escalating rapidly, with 101 million adults currently living with T2DM (ICMR-INDIAB Study)1. Compounding this crisis,...
Beyond Glycaemia- Weight Reduction Is the New Additional Therapeutic Endpoint in T2D Dr. Kamal Kant Kohli7 March 2026 10:59 AM ISTIndia bears a disproportionate share of the global diabetes burden, with 89.8 million adults living with T2DM against a worldwide estimate of 589...
Absorption Enhancer in Oral Semaglutide Linked to Gut and Inflammatory Changes: Study Medha Baranwal7 March 2026 9:00 AM ISTAustralia: A preclinical study published in the Journal of Controlled Release suggests that salcaprozate sodium, an absorption enhancer used in oral...
Semaglutide may Improve Metabolic Control in Latent Autoimmune Diabetes in Adults, Finds Study Medha Baranwal6 March 2026 11:00 AM ISTItaly: A retrospective study published in the Journal of Clinical Endocrinology & Metabolism has found that patients with latent autoimmune...
India's Semaglutide Market Set for Generic Boom as Patents Expire, Over 50 Brands Lined Up for Launch, See Full List Farhat Nasim4 March 2026 10:15 PM ISTNew Delhi: The expiry of semaglutide's key patent in India in March 2026 is ushering in a tsunami of generic versions of the blockbuster diabetes and...
7 Pharma Firms Eye Generic Semaglutide, Prices May Fall 50% Post Patent Expiry: Report Parthika Patel27 Feb 2026 7:40 PM ISTNew Delhi: Prices of widely used weight-loss drugs such as Wegovy and Ozempic are expected to drop significantly in India after the semaglutide patent...
Dr Reddy's Prepares Generic Semaglutide Entry Under Brand Obeda, Targets 60% Price Cut: Report Parthika Patel26 Feb 2026 10:01 PM ISTMumbai: Indian drugmaker Dr Reddy's Laboratories is likely to launch its generic semaglutide injection in the country in March under the brand name...
CagriSema Fails to Demonstrate Noninferiority to Tirzepatide for Weight Loss: Phase 3 REDEFINE Trial Dr. Kamal Kant Kohli24 Feb 2026 9:15 AM ISTTopline results from a phase 3 clinical trial compared CagriSema with tirzepatide in patients with obesity. CagriSema is a fixed-dose combination of...
Natco Pharma's Generic Semaglutide to Hit Indian Market in March Parthika Patel14 Feb 2026 9:26 PM ISTNew Delhi: Natco Pharma Limited has received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and market...
